These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 2946557)

  • 1. The value of synthetic peptides as vaccines for eliciting T-cell immunity.
    Schwartz RH
    Curr Top Microbiol Immunol; 1986; 130():79-85. PubMed ID: 2946557
    [No Abstract]   [Full Text] [Related]  

  • 2. In vivo and in vitro requirements for T-cell activation: concordance and contrasts.
    Owens T
    Cell Immunol; 1984 Nov; 89(1):232-4. PubMed ID: 6237737
    [No Abstract]   [Full Text] [Related]  

  • 3. The T-lymphocyte response to varicella-zoster viral proteins.
    Arvin AM; Koropchak CM; Sharp M; Bergen R; Diaz PS
    Adv Exp Med Biol; 1990; 278():71-81. PubMed ID: 1963047
    [No Abstract]   [Full Text] [Related]  

  • 4. Helper and cytotoxic T cell responses of HIV type 1-infected individuals to synthetic peptides of HIV type 1 Rev.
    Blazevic V; Ranki A; Krohn KJ
    AIDS Res Hum Retroviruses; 1995 Nov; 11(11):1335-42. PubMed ID: 8573390
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Specific T helper cell requirement for optimal induction of cytotoxic T lymphocytes against major histocompatibility complex class II negative tumors.
    Ossendorp F; Mengedé E; Camps M; Filius R; Melief CJ
    J Exp Med; 1998 Mar; 187(5):693-702. PubMed ID: 9480979
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of synthetic vaccines in the induction of cytotoxic T lymphocytes. Comparison of the costimulating support provided by helper T cells and lipoamino acid.
    Borges E; Wiesmüller KH; Jung G; Walden P
    J Immunol Methods; 1994 Aug; 173(2):253-63. PubMed ID: 7519223
    [TBL] [Abstract][Full Text] [Related]  

  • 7. T-cell immunity to oncogenic proteins including mutated ras and chimeric bcr-abl.
    Cheever MA; Chen W; Disis ML; Takahashi M; Peace DJ
    Ann N Y Acad Sci; 1993 Aug; 690():101-12. PubMed ID: 8103658
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elicitation of T-lymphocyte responses by major histocompatibility complex encoded determinants.
    Bach FH
    Prog Clin Biol Res; 1984; 149():221-33. PubMed ID: 6204339
    [No Abstract]   [Full Text] [Related]  

  • 9. T cell subsets and graft-versus-host disease.
    Korngold R; Sprent J
    Transplantation; 1987 Sep; 44(3):335-9. PubMed ID: 2957834
    [No Abstract]   [Full Text] [Related]  

  • 10. Cytotoxic and helper T-lymphocyte responses to antibody recognition regions on influenza virus hemagglutinin.
    Atassi MZ; Torres JV; Wyde PR
    Adv Exp Med Biol; 1989; 251():49-63. PubMed ID: 2532857
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Network regulation among T cells; conclusions from limiting dilution experiments.
    Eichmann K; Fey K; Kuppers R; Melchers I; Simon MM; Weltzien HU
    Springer Semin Immunopathol; 1983; 6(1):7-32. PubMed ID: 6225199
    [No Abstract]   [Full Text] [Related]  

  • 12. The optimization of helper T lymphocyte (HTL) function in vaccine development.
    Alexander J; Fikes J; Hoffman S; Franke E; Sacci J; Appella E; Chisari FV; Guidotti LG; Chesnut RW; Livingston B; Sette A
    Immunol Res; 1998; 18(2):79-92. PubMed ID: 9844827
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessing CD4+ helper T-lymphocyte responses by lymphoproliferation.
    Quakyi IA; Ahlers JD
    Methods Mol Med; 2002; 72():369-83. PubMed ID: 12125133
    [No Abstract]   [Full Text] [Related]  

  • 14. Immunoregulatory T lymphocytes in man. Cell surface molecules involved in their function.
    Damle NK; Engleman EG
    Year Immunol; 1985; ():39-50. PubMed ID: 2953144
    [No Abstract]   [Full Text] [Related]  

  • 15. The role of functional cell surface antigens in T cell activation.
    Bierer BE; Mentzer SJ; Greenstein JL; Burakoff SJ
    Year Immunol; 1986; 2():39-59. PubMed ID: 2953146
    [No Abstract]   [Full Text] [Related]  

  • 16. Synthetic Plasmodium falciparum circumsporozoite peptides elicit heterogenous L3T4+ T cell proliferative responses in H-2b mice.
    Togna AR; Del Giudice G; Verdini AS; Bonelli F; Pessi A; Engers HD; Corradin G
    J Immunol; 1986 Nov; 137(9):2956-60. PubMed ID: 2428881
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytotoxic T-lymphocyte-, and helper T-lymphocyte-oriented DNA vaccination.
    Nagata T; Aoshi T; Uchijima M; Suzuki M; Koide Y
    DNA Cell Biol; 2004 Feb; 23(2):93-106. PubMed ID: 15000749
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unique T-cell immune abnormalities in the development of acquired immune deficiency syndrome (AIDS).
    Shearer GM; Bernstein DC
    Cancer Invest; 1986; 4(6):599-608. PubMed ID: 2950971
    [No Abstract]   [Full Text] [Related]  

  • 19. Helper-cytotoxic T lymphocyte (CTL) determinant linkage required for priming of anti-HIV CD8+ CTL in vivo with peptide vaccine constructs.
    Shirai M; Pendleton CD; Ahlers J; Takeshita T; Newman M; Berzofsky JA
    J Immunol; 1994 Jan; 152(2):549-56. PubMed ID: 8283036
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conditioned dendritic cells as a temporal bridge between T helper and cytotoxic cells.
    Hall BM; Chen J; Robinson C; He XY; Plain K; Verma N; Hodgkinson ST
    Transplant Proc; 2001; 33(1-2):195-6. PubMed ID: 11266776
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.